Back to Results
First PageMeta Content
Health / Lamivudine / Nevirapine / Antiretroviral drug / Zidovudine / Reverse-transcriptase inhibitor / Viral load / HIV / AIDS / HIV/AIDS / Medicine / Chemistry


ORIGINAL CONTRIBUTION Lamivudine-Zidovudine Combination for Prevention of Maternal-Infant Transmission of HIV-1 Laurent Mandelbrot, MD
Add to Reading List

Open Document

File Size: 270,44 KB

Share Result on Facebook

City

Paris / Bondy / Cary / Lyon / Basel / Marseille / Cochin / Courtaboeuf / Emeryville / Chatillon / subSaharan Africa / Colombes / Nice / Toulouse / Lille / Chicago / /

Company

SAS Institute Inc / Chiron Corp / M184V Mutation / Congenital Anomalies Working Group / Drug Resistance Genotypes Genotyping / LamivudineZidovudine Group / Fondation de France / Quiagen Ltd / Fiscus SA / Bristol-Myers Squibb / Dell / AIDS Clinical Trial Group / Pfizer / Dupont / Perinatal HIV Guidelines Working Group / /

Continent

Europe / Africa / North America / /

Country

Switzerland / France / United Kingdom / Finland / United States / /

Currency

USD / /

/

Event

M&A / Product Recall / Product Issues / /

Facility

Port Royal / /

IndustryTerm

intervention / multivariable analysis accounting / control / imaging / sequence navigator software / historical control / /

MedicalCondition

hydrocephalus / HIV / moderate-to-severe anemia / Ito nevus / sickle cell anemia / Guillain-Barre´ syndrome / hypospadia / HIV RNA / moderate-tosevere neutropenia / Major birth defects / persistent serious anemia / moderateto-severe anemia / birth defects / mitochondrial dysfunction / genetic disease / hydronephrosis / metabolic acidosis / neutropenia / HIV seropositivity / vomiting / AIDS / infection / infectious disease / suburethral cyst / Down syndrome / maternal disease / §HIV infection / mL. ternal HIV disease / Neurologic signs / †Advanced disease / pregnancy complications / persistent moderate neutropenia / Withdrawal syndrome / hematologic disorders / febrile seizures / et al. Perinatal HIV infection / tachycardia / utero reported anemia / MS / maternal-fetal bacterial infections / HIV Infection / Opportunistic Infections / disease / dyspnea / advanced HIV infection / congenital diaphragmatic hernia / imperforate anus / advanced maternal immune deficiency / advanced maternal disease / lactic acidosis / fatal neurologic disorders / only moderate-to-severe anemia / polydactyly / anemia / /

MedicalTreatment

highly active antiretroviral therapy / chemoprophylaxis / antiretroviral treatment / antiretroviral therapy / blood transfusion / antiretroviral therapies / /

OperatingSystem

Aix / /

Organization

Adverse Effects Validation Committee / Department of Internal Medicine / Department of ObstetricsGynecology / Institut National / Data and Safety Monitoring Board / Institut Mutualiste Montsouris / Sidaction Fund / national drug agency / LAMIVUDINE-ZIDOVUDINE AND MATERNAL HIV-1 TRANSMISSION mission / Public Health Service Task Force / ANRS / American Medical Association / Scientific Committee / Hopital Biceˆtre-Pharmacie Centrale / Lamivudine administration / Department of Obstetrics-Gynecology / /

Person

Christine Rouzioux / Jean Louis Be´nifla / Jean Verdier / Alain Berrebi / B. Clavier / V / Mandelbrot / Robert Debre / Marie-Jeanne Mayaux / Nicole Ciraru-Vigneron / Marianne Burgard / Marie-Laure Chaix / Aline Landreau-Mascaro / Eric Lachassine / Catherine Crenn-He / Louis Be / Blanche / Delfraissy / E. Lachassine / V / Louis Mourier / Bongain / F. David Ouaknine / Claire Rekacewicz / Guillaume Walkenaer / /

Position

RT / Author / investigator / wild-type RT / Corresponding Author / Fisher / /

Product

nevirapine / Zidovudine / syndromes / Lamivudine / /

ProvinceOrState

North Dakota / Illinois / Oregon / Warrington / /

Region

sub-Saharan Africa / /

Technology

placebo.1 Protocol / pharmacokinetics / DNA synthesis / http / /

URL

http /

SocialTag